# Blood Glucose Self Monitoring and HbA1c Effects on Glucose Control

> **NCT00688363** · PHASE4 · COMPLETED · sponsor: **Deutsche Diabetes Gesellschaft** · enrollment: 300 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **PROCEDURE:** weekly blood glucose profile
- **PROCEDURE:** three-monthly haemoglobin A1c
- **PROCEDURE:** no blood-glucose self-control

## Key facts

- **NCT ID:** NCT00688363
- **Lead sponsor:** Deutsche Diabetes Gesellschaft
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2008-09
- **Final completion:** 2008-12
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2011-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00688363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00688363, "Blood Glucose Self Monitoring and HbA1c Effects on Glucose Control". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00688363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
